Danazol treatment of advanced prostate cancer: Clinical and hormonal effects
Danazol treatment of 19 advanced prostate cancer patients showed no objective remissions but stable disease in 15.8% of cases, alongside significant tumor flare reactions and potential treatment-related mortality.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (14)
- Danazol effects on gowadotrop in basal levels and pituitary responsiveness to lh-rn in immature male rats via openalex
- Danazol increasingly used. via openalex
- Danazol Inhibits Steroidogenesis via openalex
- Danazol treatment of advanced breast cancer. via openalex
- Effects of Danazol on Pituitary Gonadotrophins in Post‐Menopausal Women via openalex
- Further studies on danazol interference in testosterone radioimmunoassays. via openalex
- Further studies on danazol interference in testosterone radioimmunoassays. via openalex
- Pituitary and Testicular Function Studies. I. Experience with a New Gonadal Inhibitor, 17α-Pregn-4-en-20-yno-(2,3-d) isoxazol-17-ol (Danazol)<sup>1</sup> via openalex
- Pituitary Gonadotropin Responsiveness with Danazol via openalex
- The Effect of Danazol on Anterior Pituitary Function via openalex
- W6643992471 via openalex
- doi:10.1002/pros.2990050405 via openalex
- doi:10.1095/biolreprod10.4.438 via openalex
- doi:10.1016/s0015-0282(16)43953-1 via openalex
Source provenance
- openalex
- last seen: 2026-05-10T18:12:33.072680+00:00